ScoreWhy is Biocon Ltd. ?
1
Positive results in Mar 26
- PAT(Latest six months) Higher at Rs 627.61 cr
- PBT LESS OI(Q) At Rs 275.40 cr has Grown at 70.7% (vs previous 4Q average)
- DEBT-EQUITY RATIO(HY) Lowest at 0.45 times
2
Stock is technically in a Bullish range
- The technical trend has improved from Mildly Bullish on 20-May-26
- Multiple factors for the stock are Bullish like MACD, Bollinger Band, KST and OBV
3
With ROCE of 3.2, it has a Attractive valuation with a 1.8 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 30.21%, its profits have fallen by -21.1%
4
Rising Promoter Confidence
- Promoters have increased their stake in the company by 14.5% over the previous quarter and currently hold 44.91% of the company
- Promoters increasing their stake is a sign of high confidence in the future of the business
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Biocon should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Biocon for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Biocon
20.53%
1.15
26.32%
Sensex
-5.06%
-0.64
13.06%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
18.83%
EBIT Growth (5y)
9.87%
EBIT to Interest (avg)
4.90
Debt to EBITDA (avg)
4.70
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
0.43
Tax Ratio
17.66%
Dividend Payout Ratio
5.92%
Pledged Shares
0
Institutional Holding
31.59%
ROCE (avg)
5.98%
ROE (avg)
4.94%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
89
Industry P/E
34
Price to Book Value
1.96
EV to EBIT
52.82
EV to EBITDA
22.76
EV to Capital Employed
1.72
EV to Sales
4.62
PEG Ratio
NA
Dividend Yield
0.10%
ROCE (Latest)
3.25%
ROE (Latest)
2.21%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend18What is working for the Company
PAT(Latest six months)
Higher at Rs 627.61 cr
PBT LESS OI(Q)
At Rs 275.40 cr has Grown at 70.7% (vs previous 4Q average
DEBT-EQUITY RATIO(HY)
Lowest at 0.45 times
NET SALES(Q)
Highest at Rs 4,516.60 cr
-5What is not working for the Company
ROCE(HY)
Lowest at 3.69%
PAT(Q)
At Rs 190.41 cr has Fallen at -14.2% (vs previous 4Q average
Loading Valuation Snapshot...
Here's what is working for Biocon
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 275.40 cr has Grown at 70.7% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 161.30 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Net Sales - Quarterly
Highest at Rs 4,516.60 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Debt-Equity Ratio - Half Yearly
Lowest at 0.45 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Biocon
Profit After Tax (PAT) - Quarterly
At Rs 190.41 cr has Fallen at -14.2% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 221.89 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
